Merck KGaA downgraded to sell from buy at Stifel (€111.25, 0.00)
Merck KGaA closes acquisition of SpringWorks Therapeutics, Inc. ($46.99, 0.00)
Springworks Therapeutics shareholder approve merger agreement with Merck KGaA - 8-K ($46.99, 0.00)
EMA CHMP publishes summary of opinions for June 2025 meeting
StreetAccount Summary: EU stocks reaching new 52-week highs/lows (80 total)
Powered by FactSet Research Systems Inc.